MGI:2445096Null mice show progressive muscle weakness and atrophy, motor and sensory dysfunctions, decreased nerve conduction velocity, increased 2-ketoadipic acid and 2-aminoadipic acid in urine, elevated insulin levels, myelin damage and axonal degeneration.